
Servier is conducting a phase III clinical trial investigating a treatment option for IDH1-mutated MDS that has not been treated by a class of drugs called HMAs.
To learn more
➡️ Contact scientificinformation@servier.com
➡️ Speak with your doctor
➡️ Visit bit.ly/PyramIDH

English





















